AIP
NAGE

Ameritas Investment Partners’s Niagen Bioscience NAGE Stock Holding History

Ameritas Investment Partners’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.2K Hold
4,797
– – ﹤0.01% 2568
2025
Q4 		$30.5K Hold
4,797
– – ﹤0.01% 2430
2025
Q3 		$44.8K Hold
4,797
– – ﹤0.01% 2207
2025
Q2 		$69.1K Hold
4,797
– – ﹤0.01% 1983
2025
Q1 		$33.1K Hold
4,797
– – ﹤0.01% 2332
2024
Q4 		$25.4K Hold
4,797
– – ﹤0.01% 2529
2024
Q3 		$17.5K Hold
4,797
– – ﹤0.01% 2716
2024
Q2 		$13.1K Buy
+4,797
New +$16.1K ﹤0.01% 2818
2022
Q2 		– Sell
-3,310
Closed -$8K – 3267
2022
Q1 		$8K Hold
3,310
– – ﹤0.01% 2869
2021
Q4 		$12K Hold
3,310
– – ﹤0.01% 2848
2021
Q3 		$21K Hold
3,310
– – ﹤0.01% 2681
2021
Q2 		$33K Hold
3,310
– – ﹤0.01% 2457
2021
Q1 		$31K Hold
3,310
– – ﹤0.01% 2367
2020
Q4 		$16K Hold
3,310
– – ﹤0.01% 2594
2020
Q3 		$13K Hold
3,310
– – ﹤0.01% 2607
2020
Q2 		$15K Hold
3,310
– – ﹤0.01% 2519
2020
Q1 		$11K Hold
3,310
– – ﹤0.01% 2521
2019
Q4 		$14K Hold
3,310
– – ﹤0.01% 2603
2019
Q3 		$13K Hold
3,310
– – ﹤0.01% 2627
2019
Q2 		$15K Hold
3,310
– – ﹤0.01% 2620
2019
Q1 		$14K Hold
3,310
– – ﹤0.01% 2567
2018
Q4 		$11K Hold
3,310
– – ﹤0.01% 2637
2018
Q3 		$14K Hold
3,310
– – ﹤0.01% 2703
2018
Q2 		$12K Buy
+3,310
New +$12.6K ﹤0.01% 2790
2017
Q2 		– Sell
-2,230
Closed -$6K – 3054
2017
Q1 		$6K Buy
+2,230
New +$6.32K ﹤0.01% 2819

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameritas Investment Partners's NAGE Position: Q1 2026 in Review

Ameritas Investment Partners held its Niagen Bioscience (NAGE) position steady in Q1 2026 at 4,797 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2568.

Ameritas Investment Partners first reported a position in NAGE in Q1 2017 and has held it in 25 quarters since. The position peaked at $69.1K in Q2 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Ameritas Investment Partners held 4,797 shares of Niagen Bioscience worth $21.2K as of Q1 2026.
  • Ameritas Investment Partners left its Niagen Bioscience share count unchanged in Q1 2026.
  • Niagen Bioscience made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2568 holding.
  • Ameritas Investment Partners first reported a position in Niagen Bioscience in Q1 2017 and has held it in 25 quarters since.
  • Ameritas Investment Partners's Niagen Bioscience position peaked at $69.1K in Q2 2025.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.